HCID 86636612, compound → HCID 44467020, compound
Reaction equation
[C:1]([N:4]1[CH2:9][CH2:8][N:7]([C:10]2[CH:15]=[CH:14][C:13]([NH:16][C:17]3[N:22]=[C:21]([N:23]4[CH2:28][CH2:27][CH2:26][CH2:25][CH:24]4[CH2:29][NH:30]C(=O)OC(C)(C)C)[C:20]([F:38])=[CH:19][N:18]=3)=[CH:12][CH:11]=2)[CH2:6][CH2:5]1)(=[O:3])[CH3:2]>C(O)(C(F)(F)F)=O>[NH2:30][CH2:29][CH:24]1[CH2:25][CH2:26][CH2:27][CH2:28][N:23]1[C:21]1[C:20]([F:38])=[CH:19][N:18]=[C:17]([NH:16][C:13]2[CH:12]=[CH:11][C:10]([N:7]3[CH2:8][CH2:9][N:4]([C:1](=[O:3])[CH3:2])[CH2:5][CH2:6]3)=[CH:15][CH:14]=2)[N:22]=1Participants
3
Reactant 1
Product 1
Reagents, catalysts & solvents 1
Procedure
A solution of tert-butyl (1-(2-(4-(4-acetylpiperazin-1-yl)phenylamino)-5-fluoropyrimidin-4-yl)piperidin-2-yl)methylcarbamate (56 mg, 0.11 mmol) in TFA (3 mL) was stirred at room temperature for 60 min. TFA was removed in vacuo. The residue was purified by HPLC to give the titled compound (35 mg) MS 428.4 (M+H); UV 213.8, 258.8 nm.
Workup
- customTFA was removed in vacuo
- customThe residue was purified by HPLC
Sources & evidence
- ORD record
- ord-5c5643205cd046bab1b0949b9cdb9b74
- Source dataset
- uspto-grants-2012_09
- Patent number
- US08258144B2
Reaction notes
Loading…